With sarilumab cruising toward a potential FDA approval this fall or earlier, drug developers Sanofi SA and Regeneron Pharmaceuticals Inc. reported that, at week 24, the interleukin-6 receptor ...
This article was originally published by HCPLive. In patients with polymyalgia rheumatica who relapsed while tapering prednisone, those receiving sarilumab were significantly more likely to achieve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results